Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind"), a biopharmaceutical company focused on the discovery and development of innovative therapies for metabolic diseases, announced today that China's ...

Keros Therapeutics KROS is focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming ...

Research team at OncoRay identifies MMP11 as a promising biomarker for liquid biopsy in prostate cancer Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In ...

Recent research shows that GLP-1s may help reduce the need for emergency care in those with chronic migraine. This research will be present at the upcoming American Academy of Neurology Annual Meeting ...

Epic Fury Cost. The first 100 hours days of the U.S. military operation against Iran, dubbed Epic Fury, cost $3.7 billion, or ...

In a recently published review, a research team led by MedUni Vienna has highlighted a promising new approach to drug ...

BBO-11818 is a selective, orally bioavailable non-covalent inhibitor that targets KRAS in both the ON and OFF states, has ...

Innate immune sensors—known as pattern recognition receptors (PRRs)—detect specific molecular components of bacterial or ...